Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 02 - 25 source : Www.biospace.com save search
Bio-Rad Introduces Bio-Plex Pro Human IgG SARS-CoV-2 Serology Assays
Published: 2021-02-25 (Crawled : 21:00) - biospace.com/
BIO | News | $281.94 0.33% 18K
|
Health Technology
|
| O: -0.15%
H: 0.45%
C: -1.92%
sars-cov-2
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Published: 2021-02-25 (Crawled : 21:00) - biospace.com/
CODX | $1.16 2.2K
|
Health Technology
|
| O: -2.04%
H: 4.16%
C: -5.75%
covid saliva test diagnostic
CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.0%
H: 3.46%
C: 2.83%
biopharma health
Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
TECH | $62.88 1.08% 110K
|
Health Technology
|
| O: 0.08%
H: 0.79%
C: -2.65%
CareDx Expands into the Pre-Transplant Kidney Space through TX Connect TX Connect adds 19,000 patient referrals for kidney transplant and continues CareDx’s focus on the patient journey
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
CDNA | $8.23 1.98% 70K
|
Health Technology
|
| O: 0.01%
H: 4.42%
C: 0.28%
space spac kidney
Merck to Acquire Pandion Therapeutics
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
MRK | $125.12 -0.09% 1.6M
|
Health Technology
|
| O: -0.49%
H: 1.07%
C: 0.56%
therapeutics
10x Genomics Announces New Product Lineup and Tetramer Shop Acquisition
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
TXG | $28.83 -0.42% 370K
|
Health Technology
|
| O: -1.29%
H: 1.63%
C: -2.26%
acquisition genomic new product
Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
REGN | $894.35 0.04% 140K
|
Health Technology
|
| O: 0.37%
H: 1.02%
C: -1.55%
covid phase 3 trial casirivimab
BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related AgitationTopline results are expected in Q1 2022
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
BTAI | $2.715 6.47% 180K
|
Health Technology
|
| O: 0.84%
H: 5.05%
C: -4.02%
treatment phase 2 results trial
Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
ENVB | $0.938 15K
|
Health Technology
|
| O: 4.5%
H: 0.2%
C: -8.82%
collaboration program bioscience
Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
NKTR | $1.275 -3.41% 270K
|
Health Technology
|
| O: 0.04%
H: 1.36%
C: -1.49%
disease treatment collaboration computational license research antibody potential designation
ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
Published: 2021-02-25 (Crawled : 18:00) - biospace.com/
EPIX | $6.9 2.68% 4.3K
|
Health Technology
|
| O: -0.68%
H: 0.87%
C: -3.93%
prostate cancer collaboration cancer
Humanigen to Present at Multiple Investor Conferences in March
Published: 2021-02-25 (Crawled : 18:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.53%
H: 0.2%
C: -7.03%
conference presentation
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-25 (Crawled : 18:00) - biospace.com/
NEO | News | $13.685 -0.62% 86K
|
Health Services
|
| O: -1.93%
H: 0.62%
C: -4.56%
genomic svb leerink global
Theratechnologies Announces Fourth Quarter and Fiscal Year 2020 Financial ResultsRecord Q4 and FY2020 revenues of $19.1 million and $66.1 million, respectively
Published: 2021-02-25 (Crawled : 18:00) - biospace.com/
THTX | $1.29 320
|
Health Technology
|
| O: -3.17%
H: 2.62%
C: 1.64%
financial results results
NLS Pharmaceutics to Participate in Upcoming Investor Conferences
Published: 2021-02-25 (Crawled : 17:00) - biospace.com/
NLSP | $0.1327 10K
|
|
| O: 4.9%
H: 0.0%
C: -7.48%
conference
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
Published: 2021-02-25 (Crawled : 16:00) - biospace.com/
GOSS 4 | $0.82 1.74% 87K
|
Health Technology
|
| O: 1.64%
H: 0.85%
C: -7.12%
financial results results
Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
CLGN | $5.22 11
|
Health Technology
|
| O: -12.51%
H: 8.74%
C: -20.07%
license
Axcella Announces Upcoming Presentations at NASH-TAG 2021
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 7.53%
H: 0.0%
C: -6.21%
nash presentation
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
AKBA | $1.345 -3.24% 550K
|
Health Technology
|
| O: -11.21%
H: 1.32%
C: -8.68%
financial results results
Gainers vs Losers
| 81% | 19% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
PAPL | $2.07 26.22% 550K
|
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.